Anteris Technologies (AU:AVR) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anteris Technologies Global Corp., a leader in structural heart innovations, has filed a report with the SEC related to their schemes of arrangement. The company is renowned for its DurAVR® Transcatheter Heart Valve, which mimics a healthy aortic valve to treat aortic stenosis. Their patented ADAPT® tissue technology has been successfully used in over 55,000 patients worldwide.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.